Ilya Pharma has closed a 8.5 million EUR funding round where the EIC Fund participated and was joined by an international consortium of family offices and private investors
Scientific abstract of ILP100-Oral in two colitis models selected for poster at Experimental Biology Philadelphia April 4 2022
Experimental Biology (EB) is the annual meeting of five societies that explores the latest research in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Participants represent scientists from academic institutions, government agencies, nonprofit organizations and industry.
Largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Ilya Pharma will present clinical and corporate updates at Biotech Showcase 10-13 January at JPM Week 2022
Ilya Pharma shares latest developments of ILP100-Oral at virtual conference 7th of December showcasing innovations in gut therapeutics
Professor Mia Phillipson will present Nature Conferences Innovative Tissue Therapies from Bench to Bedside 16-18 November
Abstract: "The ILP-technology platform is scalable and enables efficient delivery of immunoregulatory proteins locally on-site – lead program in clinical phase 2 developments"